A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial (Q45866533)
Jump to navigation
Jump to search
scientific article published in February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial |
scientific article published in February 2011 |
Statements
1 reference
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial (English)
1 reference
1 reference
Mariann Gyöngyösi
1 reference
Jens Kastrup
1 reference
Erik Jørgensen
1 reference
Shmuel Fuchs
1 reference
Sigrid Nikol
1 reference
Dietmar Glogar
1 reference
Ran Kornowski
1 reference
1 February 2011
1 reference
1 reference
6
1 reference
7
1 reference
813-818
1 reference
Identifiers
1 reference
1 reference